LBO — LOVELACE WOMENS HOSPITAL
IRR: 18.7% | MOIC: 2.36x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
18.7%
IRR
2.36x
MOIC
$160.8M
Entry EV
$262.9M
Exit EV
$82.7M
Equity Invested
Sources & Uses
S&UTotal · $160.8M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $62.4M | 38.8% | |
| Sub Debt | $15.6M | 9.7% | |
| Equity | $82.7M | 51.5% | |
| Enterprise Value | $156.1M | 97.1% | |
| Transaction Fees | $4.7M | 2.9% | |
| Total Uses | $160.8M | 100.0% |
Interpretation
INTAt 2.36x MOIC and 18.7% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $25.0M |
| Exit Ev | $262.9M |
| Net Debt At Exit | $67.8M |
| Equity At Exit | $195.1M |
| Equity Invested | $82.7M |
| Total Value Created | $112.4M |
| Value From Growth | $99.0M |
| Value From Multiple | $7.8M |
| Value From Deleveraging | $10.3M |